FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3033686149> ?p ?o ?g. }

• W3033686149 abstract "Abstract Background In the era of “test and treat strategy”, CD4 testing remains an important tool for monitoring HIV-infected individuals. Since conventional methods of CD4 count measurement are costly and cumbersome, POC CD4 counting technique are more affordable and practical for countries with limited resources. Before introducing such methods in Morocco, we decided to assess their reliability. Methods In this study 92 blood samples from HIV-infected patients, were tested by PIMA and FACSPresto to derive CD4 count. Flow cytometry using FacsCalibur, was used as reference method for CD4 count comparison. Linear regression, Bland–Altman analysis were performed to assess correlation and agreement between these POC methods and the reference method. In addition, sensitivity and specificity, positive predictive value (PPV), negative predictive value (NPV) and misclassification percentage at 350 and 200 CD4 count thresholds; were also determined. Finally, because FACSPresto can also measure hemoglobin (Hb) concentration, 52 samples were used to compare FACSPresto against an automated hematology analyzer. Results The coefficient of determination R 2 was 0.93 for both methods. Bland–Altman analysis displayed a mean bias of − 32.3 and − 8.1 cells/µl for PIMA and FACSPresto, respectively. Moreover, with a threshold of 350 CD4 count, PIMA displayed a sensitivity, specificity, PPV, NPV, were 88.57%, 94.12%, 91.18%, 92.31%; respectively. FACSPresto showed 88.23%, 96.23%, 93.75% and 92.73%; respectively. Furthermore, the upward misclassification percentage was 8.57 and 5.88%, for PIMA and FACSPresto, respectively; whereas the downward misclassification percentage was 7.84% and 7.54%; respectively. With 200 cells/µl threshold, PIMA had a sensitivity, specificity, PPV and NPV of 83.33%, 98.53%, 93.75% and 95.71%, respectively. Regarding FACSPresto, sensitivity, specificity, PPV and NPV was 82.35%, 98.57%, 88.57% and 95.83%; respectively. Upward misclassification percentage was 5.56% and 5.88%, for PIMA and FACSPresto, respectively; whereas downward misclassification percentage was 4.41% and 4.29%; respectively. Finally, the hemoglobin measurement evaluation displayed an R 2 of 0.80 and a mean bias of − 0.12 with a LOA between − 1.75 and 1.51. Conclusion When compared to the reference method, PIMA and FACSPresto have shown good performance, for CD4 counting. The introduction of such POC technology will speed up the uptake of patients in the continuum of HIV care, in our country." @default.
• W3033686149 created "2020-06-12" @default.
• W3033686149 creator A5043913279 @default.
• W3033686149 creator A5051274999 @default.
• W3033686149 creator A5057304218 @default.
• W3033686149 creator A5059460878 @default.
• W3033686149 creator A5059807572 @default.
• W3033686149 creator A5075931212 @default.
• W3033686149 date "2020-06-10" @default.
• W3033686149 modified "2023-10-16" @default.
• W3033686149 title "Assessment of two POC technologies for CD4 count in Morocco" @default.
• W3033686149 cites W1574092316 @default.
• W3033686149 cites W1797261203 @default.
• W3033686149 cites W1987566172 @default.
• W3033686149 cites W1997680551 @default.
• W3033686149 cites W2001936352 @default.
• W3033686149 cites W2007394829 @default.
• W3033686149 cites W2044944058 @default.
• W3033686149 cites W2071946557 @default.
• W3033686149 cites W2073620484 @default.
• W3033686149 cites W2078956998 @default.
• W3033686149 cites W2083404547 @default.
• W3033686149 cites W2121174293 @default.
• W3033686149 cites W2149915295 @default.
• W3033686149 cites W2152505869 @default.
• W3033686149 cites W2460768747 @default.
• W3033686149 cites W2468134620 @default.
• W3033686149 cites W2523186471 @default.
• W3033686149 cites W2533149936 @default.
• W3033686149 cites W2578256220 @default.
• W3033686149 cites W2580809580 @default.
• W3033686149 cites W2767155535 @default.
• W3033686149 cites W2793106341 @default.
• W3033686149 cites W2809832162 @default.
• W3033686149 cites W2885497094 @default.
• W3033686149 cites W2903198526 @default.
• W3033686149 cites W2904644210 @default.
• W3033686149 doi "https://doi.org/10.1186/s12981-020-00289-w" @default.
• W3033686149 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7285615" @default.
• W3033686149 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32522235" @default.
• W3033686149 hasPublicationYear "2020" @default.
• W3033686149 type Work @default.
• W3033686149 sameAs 3033686149 @default.
• W3033686149 citedByCount "3" @default.
• W3033686149 countsByYear W30336861492021 @default.
• W3033686149 countsByYear W30336861492022 @default.
• W3033686149 countsByYear W30336861492023 @default.
• W3033686149 crossrefType "journal-article" @default.
• W3033686149 hasAuthorship W3033686149A5043913279 @default.
• W3033686149 hasAuthorship W3033686149A5051274999 @default.
• W3033686149 hasAuthorship W3033686149A5057304218 @default.
• W3033686149 hasAuthorship W3033686149A5059460878 @default.
• W3033686149 hasAuthorship W3033686149A5059807572 @default.
• W3033686149 hasAuthorship W3033686149A5075931212 @default.
• W3033686149 hasBestOaLocation W30336861491 @default.
• W3033686149 hasConcept C105795698 @default.
• W3033686149 hasConcept C126322002 @default.
• W3033686149 hasConcept C142462285 @default.
• W3033686149 hasConcept C203014093 @default.
• W3033686149 hasConcept C2776376844 @default.
• W3033686149 hasConcept C2989005 @default.
• W3033686149 hasConcept C2993143319 @default.
• W3033686149 hasConcept C2993758460 @default.
• W3033686149 hasConcept C3013748606 @default.
• W3033686149 hasConcept C3018577593 @default.
• W3033686149 hasConcept C3019719930 @default.
• W3033686149 hasConcept C33923547 @default.
• W3033686149 hasConcept C71924100 @default.
• W3033686149 hasConceptScore W3033686149C105795698 @default.
• W3033686149 hasConceptScore W3033686149C126322002 @default.
• W3033686149 hasConceptScore W3033686149C142462285 @default.
• W3033686149 hasConceptScore W3033686149C203014093 @default.
• W3033686149 hasConceptScore W3033686149C2776376844 @default.
• W3033686149 hasConceptScore W3033686149C2989005 @default.
• W3033686149 hasConceptScore W3033686149C2993143319 @default.
• W3033686149 hasConceptScore W3033686149C2993758460 @default.
• W3033686149 hasConceptScore W3033686149C3013748606 @default.
• W3033686149 hasConceptScore W3033686149C3018577593 @default.
• W3033686149 hasConceptScore W3033686149C3019719930 @default.
• W3033686149 hasConceptScore W3033686149C33923547 @default.
• W3033686149 hasConceptScore W3033686149C71924100 @default.
• W3033686149 hasIssue "1" @default.
• W3033686149 hasLocation W30336861491 @default.
• W3033686149 hasLocation W30336861492 @default.
• W3033686149 hasLocation W30336861493 @default.
• W3033686149 hasLocation W30336861494 @default.
• W3033686149 hasLocation W30336861495 @default.
• W3033686149 hasLocation W30336861496 @default.
• W3033686149 hasOpenAccess W3033686149 @default.
• W3033686149 hasPrimaryLocation W30336861491 @default.
• W3033686149 hasRelatedWork W1973460911 @default.
• W3033686149 hasRelatedWork W2013959259 @default.
• W3033686149 hasRelatedWork W2053739728 @default.
• W3033686149 hasRelatedWork W2096903645 @default.
• W3033686149 hasRelatedWork W2115881688 @default.
• W3033686149 hasRelatedWork W2320088843 @default.
• W3033686149 hasRelatedWork W2360788989 @default.
• W3033686149 hasRelatedWork W3033686149 @default.
• W3033686149 hasRelatedWork W4280613618 @default.
• W3033686149 hasRelatedWork W79345313 @default.

• next